Q32 Bio (QTTB) Return on Capital Employed Growth (1y) (2019 - 2026)
Q32 Bio (QTTB) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,912.31 Bn | 1,912.25 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 467.15 Bn | 462.36 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 123.00 Bn | 115.76 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.22 Bn | 61.47 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.93 Bn | 62.93 Bn | - | - |
| 8 | Argenx Se | 55.76 Bn | 50.57 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.70 Bn | 34.69 Bn | 959.66 Mn | 2,400.00 |
| 10 | Q32 Bio | 218.27 Mn | 167.52 Mn | - | 13,039.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,039.00 |
| Dec 31, 2025 | 11,554.00 |
| Sep 30, 2025 | -817.00 |
| Jun 30, 2025 | -3,483.00 |
| Mar 31, 2025 | -577.00 |
| Dec 31, 2024 | -1,990.00 |
| Sep 30, 2024 | -3,339.00 |
| Jun 30, 2024 | -378.00 |
| Mar 31, 2024 | -3,056.00 |
| Dec 31, 2023 | -96.00 |
| Sep 30, 2023 | 931.00 |
| Jun 30, 2023 | -404.00 |
| Mar 31, 2023 | 214.00 |
| Dec 31, 2022 | -1,275.00 |
| Sep 30, 2022 | -1,258.00 |
| Jun 30, 2022 | -751.00 |
| Mar 31, 2022 | -1,406.00 |
| Dec 31, 2021 | 1,129.00 |
| Sep 30, 2021 | 1,500.00 |
| Jun 30, 2021 | 1,133.00 |